SEC Filings

Filing date	Form	Description	Filing Group	View
October 31, 2022	UPLOAD	UPLOAD	Other	View HTML 0000000000-22-011842.pdf 0000000000-22-011842.rtf
October 3, 2022	DRS	Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy	Registration Statements	View HTML 0001104659-22-104874.pdf 0001104659-22-104874.rtf 0001104659-22-104874.xls
October 3, 2022	DRSLTR	Correspondence Related to Draft Registration Statement		View HTML 0001104659-22-104875.pdf 0001104659-22-104875.rtf
September 29, 2022	425	Filing of certain prospectuses and communications in connection with business combination transactions	Other	View HTML 0001104659-22-104163.pdf 0001104659-22-104163.rtf 0001104659-22-104163.xls

Data provided by Kaleidoscope.

Print Page

Email Alerts

RSS Feeds

Contact IR

Site Map Terms of Use Privacy

Contact Info

LakeShore Biopharma, Ltd.

11 Firstfield Road Suite A
Gaithersburg, Maryland 20878 USA

Tel: +86 (10) 61253627

ir@lakeshorebio.com